Anavex Life Sciences Corp. (AVXL)
1.82
-0.07
(-3.70%)
USD |
NASDAQ |
Oct 02, 16:00
1.815
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Price : 1.82 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.88 | 1.88 | 1.72 | 1.82 | 1.990M |
| Oct 01, 2026 | 2.00 | 2.01 | 1.88 | 1.89 | 2.343M |
| Sep 30, 2026 | 2.38 | 2.38 | 1.89 | 2.02 | 2.965M |
| Sep 29, 2026 | 2.35 | 2.415 | 2.31 | 2.36 | 1.756M |
| Sep 28, 2026 | 2.42 | 2.431 | 2.35 | 2.35 | 522543.0 |
| Sep 25, 2026 | 2.35 | 2.43 | 2.32 | 2.38 | 744393.0 |
| Sep 24, 2026 | 2.33 | 2.37 | 2.27 | 2.34 | 937053.0 |
| Sep 23, 2026 | 2.47 | 2.49 | 2.305 | 2.35 | 779168.0 |
| Sep 22, 2026 | 2.41 | 2.485 | 2.39 | 2.47 | 639993.0 |
| Sep 21, 2026 | 2.42 | 2.42 | 2.35 | 2.40 | 574478.0 |
| Sep 18, 2026 | 2.42 | 2.45 | 2.38 | 2.42 | 920589.0 |
| Sep 17, 2026 | 2.41 | 2.48 | 2.405 | 2.41 | 364751.0 |
| Sep 16, 2026 | 2.44 | 2.470 | 2.31 | 2.36 | 906105.0 |
| Sep 15, 2026 | 2.59 | 2.59 | 2.43 | 2.44 | 946237.0 |
| Sep 14, 2026 | 2.61 | 2.64 | 2.55 | 2.60 | 658133.0 |
| Sep 11, 2026 | 2.71 | 2.737 | 2.61 | 2.62 | 624490.0 |
| Sep 10, 2026 | 2.71 | 2.735 | 2.615 | 2.66 | 433768.0 |
| Sep 09, 2026 | 2.84 | 2.895 | 2.74 | 2.75 | 438581.0 |
| Sep 08, 2026 | 2.81 | 2.88 | 2.77 | 2.85 | 559136.0 |
| Sep 04, 2026 | 2.82 | 2.905 | 2.81 | 2.86 | 307150.0 |
| Sep 03, 2026 | 2.90 | 2.940 | 2.82 | 2.85 | 421923.0 |
| Sep 02, 2026 | 2.88 | 2.978 | 2.815 | 2.89 | 587454.0 |
| Sep 01, 2026 | 2.79 | 2.90 | 2.755 | 2.87 | 826676.0 |
| Aug 31, 2026 | 2.95 | 2.97 | 2.78 | 2.80 | 1.034M |
| Aug 28, 2026 | 3.12 | 3.13 | 2.96 | 2.99 | 893448.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 64.19 |
| Oncolytics Biotech, Inc. | 0.631 |
| Sangamo Therapeutics, Inc. | 0.1475 |
| Sarepta Therapeutics, Inc. | 17.50 |
| Anixa Biosciences, Inc. | 2.95 |
Price Related Metrics
| Price to Book Value | 1.500 |
| Earnings Yield | -8.33% |
| Market Cap | 168.71M |